RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mithra Pharmaceuticals Stock

Mithra Pharmaceuticals ROA 2024

Mithra Pharmaceuticals ROA

0

Ticker

MITRA.BR

ISIN

BE0974283153

WKN

A14V4E

In 2024, Mithra Pharmaceuticals's return on assets (ROA) was 0, a -100% increase from the -0.13 ROA in the previous year.

Mithra Pharmaceuticals Aktienanalyse

What does Mithra Pharmaceuticals do?

Mithra Pharmaceuticals SA is a Belgian pharmaceutical company specializing in women's health and hormone therapy. The company was founded in 1999 by François Fornieri and Jean-Michel Foidart and has since become a major player in women's healthcare. Its unique business model covers the entire value chain of the pharmaceutical industry, including research and development, production, distribution, and marketing of its own products. Mithra Pharmaceuticals SA collaborates with other pharmaceutical companies, universities, and public research institutions worldwide, aiming to offer innovative products and services based on new technologies and scientific knowledge. The company's divisions include hormone therapy, contraception, gynecology, and dermatology, providing a wide range of products and services tailored to women's needs. One of its notable products is the Estetrol patch, a safe and effective contraceptive containing a natural estrogen hormone produced during pregnancy. In gynecology, Mithra Pharmaceuticals SA offers products for the treatment of menstrual disorders, endometriosis, and vaginal dryness, such as the Estelle pill concept, which combines contraception and hormone regulation. In dermatology, the company provides skincare products based on natural ingredients, specifically designed for women with sensitive skin or skin issues. Overall, Mithra Pharmaceuticals SA focuses on meeting the needs of women and has a history of adapting to market conditions and offering innovative products and services. With its global presence and innovative products, Mithra Pharmaceuticals SA is well-positioned for future success. Mithra Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Mithra Pharmaceuticals's Return on Assets (ROA)

Mithra Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Mithra Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Mithra Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Mithra Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Mithra Pharmaceuticals stock

What is the Return on Assets (ROA) of Mithra Pharmaceuticals this year?

The Return on Assets (ROA) of Mithra Pharmaceuticals is 0 undefined this year.

What was the ROA of Mithra Pharmaceuticals compared to the previous year?

The ROA of Mithra Pharmaceuticals has increased by -100% compared to the previous year.

What consequences do high ROA have for investors of Mithra Pharmaceuticals?

A high ROA is advantageous for investors of Mithra Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Mithra Pharmaceuticals?

A low ROA can be unfavorable for investors of Mithra Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Mithra Pharmaceuticals affect the company?

An increase in ROA of Mithra Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Mithra Pharmaceuticals impact the company?

A reduction in the ROA of Mithra Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Mithra Pharmaceuticals?

Some factors that can influence the ROA of Mithra Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Mithra Pharmaceuticals important for investors?

The ROA of Mithra Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Mithra Pharmaceuticals take to improve ROA?

To improve ROA, Mithra Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Mithra Pharmaceuticals pay?

Over the past 12 months, Mithra Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mithra Pharmaceuticals is expected to pay a dividend of 0 EUR.

What is the dividend yield of Mithra Pharmaceuticals?

The current dividend yield of Mithra Pharmaceuticals is .

When does Mithra Pharmaceuticals pay dividends?

Mithra Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mithra Pharmaceuticals?

Mithra Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Mithra Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mithra Pharmaceuticals located?

Mithra Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mithra Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mithra Pharmaceuticals from 10/4/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Mithra Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Mithra Pharmaceuticals in the year 2023?

In the year 2023, Mithra Pharmaceuticals distributed 0 EUR as dividends.

In which currency does Mithra Pharmaceuticals pay out the dividend?

The dividends of Mithra Pharmaceuticals are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mithra Pharmaceuticals

Our stock analysis for Mithra Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mithra Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.